Olimel N9 (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Olimel N9 provides amino acid supplementation for conditions where protein turnover is increased or intake is insufficient.

• Post‑operative recovery: helps maintain nitrogen balance during wound healing.
• Severe trauma or burns: supports tissue repair and metabolic demand.
• Chronic renal failure on dialysis: supplies essential amino acids lost during treatment.
• Malnutrition in elderly patients: assists in preserving lean body mass.
• Critical illness in intensive care: contributes to overall nutritional support.
• Inborn errors of metabolism: provides specific amino acids required for metabolic pathways.

• The amino acid blend in Olimel N9 supplies substrates for protein synthesis, replenishes nitrogen pools, and participates in key metabolic cycles such as the Krebs cycle and neurotransmitter production. By delivering these building blocks directly into the bloodstream, it bypasses gastrointestinal absorption limitations and supports cellular growth and repair processes.

Amino acid solutions are generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Mild nausea or vomiting.
• Transient flushing or warmth sensation.
• Mild headache.
• Slight increase in serum urea nitrogen.
• Local irritation at the infusion site.
• Temporary rise in blood glucose.

Serious or Rare Side Effects

• Anaphylactic or severe hypersensitivity reaction.
• Hyperammonemia leading to neurological symptoms.
• Metabolic acidosis.
• Severe electrolyte disturbances.
• Acute renal impairment.
• Pulmonary edema in fluid‑overloaded patients.

When using Olimel N9, clinicians should consider patient‑specific factors and monitor relevant parameters.

• Renal function: assess baseline creatinine and adjust infusion volume.
• Hepatic function: monitor for signs of ammonia accumulation.
• Fluid balance: avoid overload in patients with heart failure.
• Electrolyte status: check serum electrolytes before and during therapy.
• Pregnancy and lactation: weigh potential benefits against unknown risks.
• Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Amino acid preparations can interact with certain medications and clinical conditions.

Major Interactions (Avoid)

• High‑dose levodopa: may compete for transport across the blood‑brain barrier.
• Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
• Certain antibiotics (e.g., tetracyclines): reduced absorption when given concurrently.

Moderate Interactions (Monitor Closely)

• Insulin or oral hypoglycemics: may enhance glucose‑lowering effect.
• Loop diuretics: potential for electrolyte shifts.
• Warfarin: possible alteration of INR values.
• Corticosteroids: increased protein catabolism may modify amino acid needs.